Global Immune Thrombocytopenic Purpura Therapeutics Market Research Report 2018-2030F, by Region, Type, Application/End-Use
- Published Date: 2024-08-17
- Report ID: 160819
- Pages: 150
-
Format:
Summary
The global Immune Thrombocytopenic Purpura Therapeutics market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Eltrombopag Olamine
Fostamatinib Disodium
GL-2045
Avatrombopag
BI-655064
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Amgen Inc.
Baxalta Incorporated
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eisai
Hansa Medical AB
Immunomedics, Inc.
Intas Pharmaceuticals Ltd.
Jiangsu Hengrui Medicine Co., Ltd.
Merck & Co., Inc.
Momenta Pharmaceuticals, Inc.
Novartis AG
Pfizer Inc.
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital
Clinic
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 Immune Thrombocytopenic Purpura Therapeutics of Research
1.1.1 Definition
1.1.2 Specifications of Immune Thrombocytopenic Purpura Therapeutics
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 Eltrombopag Olamine Overview
1.2.1.2 Fostamatinib Disodium Overview
1.2.1.3 GL-2045 Overview
1.2.1.4 Avatrombopag Overview
1.2.1.5 BI-655064 Overview
1.2.1.6 Others Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Hospital
1.3.1.2 Clinic
1.3.1.3 Others
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 Eltrombopag Olamine Market Size 2018-2023
3.1.1.1 Global Eltrombopag Olamine Market Size and Growth Rate 2018-2023
3.1.1.2 Global Eltrombopag Olamine Market Size by Region 2018-2023
3.1.2 Fostamatinib Disodium Market Size 2018-2023
3.1.2.1 Global Fostamatinib Disodium Market Size and Growth Rate 2018-2023
3.1.2.2 Global Fostamatinib Disodium Market Size by Region 2018-2023
3.1.3 GL-2045 Market Size 2018-2023
3.1.3.1 Global GL-2045 Market Size and Growth Rate 2018-2023
3.1.3.2 Global GL-2045 Market Size by Region 2018-2023
3.1.4 Avatrombopag Market Size 2018-2023
3.1.4.1 Global Avatrombopag Market Size and Growth Rate 2018-2023
3.1.4.2 Global Avatrombopag Market Size by Region 2018-2023
3.1.5 BI-655064 Market Size 2018-2023
3.1.5.1 Global BI-655064 Market Size and Growth Rate 2018-2023
3.1.5.2 Global BI-655064 Market Size by Region 2018-2023
3.1.6 Others Market Size 2018-2023
3.1.6.1 Global Others Market Size and Growth Rate 2018-2023
3.1.6.2 Global Others Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 Eltrombopag Olamine Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global Eltrombopag Olamine Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global Eltrombopag Olamine Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 Fostamatinib Disodium Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global Fostamatinib Disodium Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global Fostamatinib Disodium Market Estimates and Forecasts by Region 2024E-2030F
3.2.3 GL-2045 Market Estimates and Forecasts 2024E-2030F
3.2.3.1 Global GL-2045 Market Forecasts and Growth Rate 2024E-2030F
3.2.3.2 Global GL-2045 Market Estimates and Forecasts by Region 2024E-2030F
3.2.4 Avatrombopag Market Estimates and Forecasts 2024E-2030F
3.2.4.1 Global Avatrombopag Market Forecasts and Growth Rate 2024E-2030F
3.2.4.2 Global Avatrombopag Market Estimates and Forecasts by Region 2024E-2030F
3.2.5 BI-655064 Market Estimates and Forecasts 2024E-2030F
3.2.5.1 Global BI-655064 Market Forecasts and Growth Rate 2024E-2030F
3.2.5.2 Global BI-655064 Market Estimates and Forecasts by Region 2024E-2030F
3.2.6 Others Market Estimates and Forecasts 2024E-2030F
3.2.6.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
3.2.6.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Hospital Market Size 2018-2023
4.1.1.1 Global Hospital Market Size and Growth Rate 2018-2023
4.1.1.2 Global Hospital Market Size by Region 2018-2023
4.1.2 Clinic Market Size 2018-2023
4.1.2.1 Global Clinic Market Size and Growth Rate 2018-2023
4.1.2.2 Global Clinic Market Size by Region 2018-2023
4.1.3 Others Market Size 2018-2023
4.1.3.1 Global Others Market Size and Growth Rate 2018-2023
4.1.3.2 Global Others Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Hospital Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Hospital Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Hospital Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Clinic Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Clinic Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Clinic Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Others Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global Immune Thrombocytopenic Purpura Therapeutics Market Competition
7.1.1 Global Immune Thrombocytopenic Purpura Therapeutics Market by Companies
7.1.2 Global Immune Thrombocytopenic Purpura Therapeutics Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 Amgen Inc.
8.1.1 Amgen Inc. Company Profile
8.1.2 Amgen Inc. Product Portfolio
8.1.3 Amgen Inc. Business Performance
8.1.4 Amgen Inc. Development Overview
8.2 Baxalta Incorporated
8.2.1 Baxalta Incorporated Company Profile
8.2.2 Baxalta Incorporated Product Portfolio
8.2.3 Baxalta Incorporated Business Performance
8.2.4 Baxalta Incorporated Development Overview
8.3 Boehringer Ingelheim GmbH
8.3.1 Boehringer Ingelheim GmbH Company Profile
8.3.2 Boehringer Ingelheim GmbH Product Portfolio
8.3.3 Boehringer Ingelheim GmbH Business Performance
8.3.4 Boehringer Ingelheim GmbH Development Overview
8.4 Bristol-Myers Squibb Company
8.4.1 Bristol-Myers Squibb Company Company Profile
8.4.2 Bristol-Myers Squibb Company Product Portfolio
8.4.3 Bristol-Myers Squibb Company Business Performance
8.4.4 Bristol-Myers Squibb Company Development Overview
8.5 Eisai
8.5.1 Eisai Company Profile
8.5.2 Eisai Product Portfolio
8.5.3 Eisai Business Performance
8.5.4 Eisai Development Overview
8.6 Hansa Medical AB
8.6.1 Hansa Medical AB Company Profile
8.6.2 Hansa Medical AB Product Portfolio
8.6.3 Hansa Medical AB Business Performance
8.6.4 Hansa Medical AB Development Overview
8.7 Immunomedics, Inc.
8.7.1 Immunomedics, Inc. Company Profile
8.7.2 Immunomedics, Inc. Product Portfolio
8.7.3 Immunomedics, Inc. Business Performance
8.7.4 Immunomedics, Inc. Development Overview
8.8 Intas Pharmaceuticals Ltd.
8.8.1 Intas Pharmaceuticals Ltd. Company Profile
8.8.2 Intas Pharmaceuticals Ltd. Product Portfolio
8.8.3 Intas Pharmaceuticals Ltd. Business Performance
8.8.4 Intas Pharmaceuticals Ltd. Development Overview
8.9 Jiangsu Hengrui Medicine Co., Ltd.
8.9.1 Jiangsu Hengrui Medicine Co., Ltd. Company Profile
8.9.2 Jiangsu Hengrui Medicine Co., Ltd. Product Portfolio
8.9.3 Jiangsu Hengrui Medicine Co., Ltd. Business Performance
8.9.4 Jiangsu Hengrui Medicine Co., Ltd. Development Overview
8.10 Merck & Co., Inc.
8.10.1 Merck & Co., Inc. Company Profile
8.10.2 Merck & Co., Inc. Product Portfolio
8.10.3 Merck & Co., Inc. Business Performance
8.10.4 Merck & Co., Inc. Development Overview
8.11 Momenta Pharmaceuticals, Inc.
8.11.1 Momenta Pharmaceuticals, Inc. Company Profile
8.11.2 Momenta Pharmaceuticals, Inc. Product Portfolio
8.11.3 Momenta Pharmaceuticals, Inc. Business Performance
8.11.4 Momenta Pharmaceuticals, Inc. Development Overview
8.12 Novartis AG
8.12.1 Novartis AG Company Profile
8.12.2 Novartis AG Product Portfolio
8.12.3 Novartis AG Business Performance
8.12.4 Novartis AG Development Overview
8.13 Pfizer Inc.
8.13.1 Pfizer Inc. Company Profile
8.13.2 Pfizer Inc. Product Portfolio
8.13.3 Pfizer Inc. Business Performance
8.13.4 Pfizer Inc. Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
